Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-B activation
Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-B activation
复制标题
槐果碱通过抑制 NLRP3 炎性体和 NF-κB 激活减轻小鼠狼疮性肾炎
DOI:
10.1007/s12026-018-9012-9
复制
发表时间:
2018-08-01
影响因子:
4.4
通讯作者:
Yang, Ruiheng
中科院分区:
文献类型:
--
作者:
Li, Xiuzhen;Wang, Mengjun;Yang, Ruiheng
Inflammation contributes to the pathogenesis of lupus nephritis (LN), which is the most serious complication that increases mortality of systemic lupus erythematosus (SLE). Sophocarpine is a type of quinolizidine alkaloid that possesses anti-inflammatory property. This study investigated the speculation that sophocarpine might play a beneficial effect in LN. Female MRL/lpr mice received sophocarpine treatment for 8weeks. Renal function and histopathology were evaluated. The level of immune complex deposition was measured by immunofluorescent staining, and the levels of proinflammatory cytokines (IL-1, IL-6, and TNF-) and anti-double-stranded DNA (anti-dsDNA) antibodies were measured by ELISA. Western blotting was carried out to evaluate the levels of proteins involved in NLRP3 inflammasome and NF-B pathway. Sophocarpine treatment reduced urine protein excretion, blood urea nitrogen, and attenuated renal tissue damage. The levels of renal immune complex deposition, serum anti-dsDNA, and serum and renal inflammatory cytokines were significantly reduced by sophocarpine. Sophocarpine treatment reduced the levels of proteins that form NLRP3 inflammasome. Activation of NF-B in the kidney was inhibited by sophocarpine. Sophocarpine could ameliorate experimental LN in MRL/lpr. These effects might be through suppressing NLRP3 inflammasome and NF-B pathway.